Welcome to our dedicated page for Functional Brands news (Ticker: MEHA), a resource for investors and traders seeking the latest updates and insights on Functional Brands stock.
Functional Brands, Inc. (NASDAQ: MEHA) is a health and wellness company whose news flow centers on its science-based consumer brands, capital markets activity and strategic partnerships. The company regularly issues updates from Lake Oswego, Oregon, highlighting developments across its portfolio, which includes Kirkman®, P2i by Kirkman®, Hemptown Naturals and Healthy Assist by Kirkman.
Investors following MEHA news can expect announcements on product launches and enhancements, such as the Kirkman Skin, Beauty & Anti-Aging Bundle featuring reduced glutathione, zinc cream, biotin and grapefruit seed extract. The company also publishes detailed updates on its P2i by Kirkman prenatal supplement, including alignment with the International Federation of Gynecology and Obstetrics (FIGO) transparency standards and compliance with California’s SB 646 QR-code disclosure requirements for heavy metal testing.
Functional Brands’ news feed also covers financial and regulatory milestones. Examples include quarterly financial results, details of its direct listing on the Nasdaq Capital Market under the symbol MEHA and related SEC disclosures. Strategic communications, such as shareholder letters, outline the company’s mission of "Making Everyone Healthy Again" and describe priorities for growing the Kirkman brand, expanding prenatal offerings and developing direct-to-consumer platforms.
In addition, MEHA news items feature partnership announcements, including a commercial collaboration with Market Performance Group to expand Kirkman’s reach across eCommerce, retail and digital channels, as well as participation in investor conferences. For readers and market participants, the MEHA news page serves as a centralized view of product, financial, partnership and corporate updates directly sourced from the company’s public communications.
Functional Brands (NASDAQ: MEHA) reported first quarter 2026 results for the period ended March 31, 2026.
Revenue was $1.65 million, up 3.5% year-over-year, with gross profit of $0.96 million and gross margin of 58.4%. Operating loss widened to $0.68 million and net loss reached $7.0 million, mainly due to a $6.3 million non-cash charge on equity exchange. The company highlighted direct-to-consumer demand, expansion of Kirkman distribution, traction for Tru2u.health, broader P2i Prenatal placement, a strategic AI partnership, a binding LOI to acquire intellectual property and blockchain-based assets, and completion of a capital structure simplification.
Functional Brands (NASDAQ: MEHA) entered a Conversion Price Reduction and Waiver Agreement with all holders of its Series C Convertible Preferred Stock.
The Series C conversion price during the Fixed Conversion Period is now $0.1636 per common share, replacing prior tiered pricing and waiving below-price conversion limits at this level.
Functional Brands (NASDAQ: MEHA) signed a binding Letter of Intent to acquire the assets of BullionFX | Alchemy in an all-stock deal valued at approximately $142.9 million.
The BullionFX Assets include a blockchain-based, gold-backed DeFi ecosystem designed to link audited physical gold with digital financial applications for retail and institutional users.
Functional Brands (NASDAQ: MEHA) launched GLP-Squared Injection, a dual-peptide formulation combining Semaglutide and Tirzepatide, available exclusively through its Tru2u.health digital platform effective May 6, 2026. The therapy is clinician-prescribed, requires telehealth consultation and lab screening, and is fulfilled via the Tru2u.health ecosystem.
The company positions GLP-Squared as a precision, clinician‑supervised option aiming to deliver combined appetite regulation, glycemic control, and adipose reduction; access is limited to qualifying Tru2u.health members after provider approval.
Functional Brands (NASDAQ: MEHA) expanded its digital health platform Tru2u.health on April 29, 2026 by adding clinically supervised NAD+ therapy.
The platform now combines NAD+ with peptide protocols, GLP-1 weight management, board-certified telehealth, and clean supplements, and is onboarding patients nationwide subject to state telehealth rules.
Functional Brands (NASDAQ: MEHA) announced a strategic technology partnership with partnrup.ai to deploy its AI partner-marketing stack for Tru2u.health. The integration will make partnrup.ai the primary AI partner technology provider, target improved cost-per-acquisition and revenue-per-visitor metrics, and is expected to be fully operational within 10 days.
Management says successful deployment may allow expansion of partnrup.ai across Functional Brands' broader portfolio to scale digital revenue capabilities.
Functional Brands (NASDAQ: MEHA) launched the Kirkman Weight Loss Support Bundle on April 17, 2026, a non-prescription three-product pack targeting digestion, metabolism, and muscle preservation.
The bundle pairs Pro Bio Gold, L-Carnitine, and L-Glutamine to reduce bloating, support fat metabolism, curb sugar cravings, and help retain lean muscle. Available at Kirkman's website and through practitioners.
Functional Brands (NASDAQ: MEHA) reported Q4 2025 revenue of $1.50M (down ~11% YoY) and Q4 net income of $0.9M ($0.01 diluted) versus a prior-year loss. Full-year 2025 revenue was $6.61M (+0.7% YoY) with net income of $0.8M ($0.01 diluted).
Gross margins compressed—Q4 margin 44.9% (down 1400 bps) and full-year margin 52.7% (down 220 bps)—driven by a shift in Amazon selling model and inventory adjustments from exiting the hemp business. Management launched Tru2u.health and expanded Kirkman distribution internationally.
Functional Brands (NASDAQ: MEHA) announced that P2i by Kirkman prenatal multivitamin is now available globally through iHerb as of March 20, 2026. The partnership expands international distribution across Asia, Europe, the Middle East, and Latin America and highlights P2i's testing for contaminants and clean-ingredient formulation.
P2i is tested for over 160 potential threats and is formulated without GMOs, titanium dioxide, dyes, or unnecessary fillers.
Functional Brands (NASDAQ: MEHA) will participate in the 38th Annual ROTH Conference in Dana Point, California, March 22-24, 2026. CEO Eric Gripentrog and Financial Counsel David R. Wells will meet with investors in one-on-one and small-group sessions.
The company will join analyst firesides, industry presentations, and panel discussions; investors can request registration via the conference registration link.